Author

Maree Pechlivanis

Peter MacCallum Cancer Centre

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Research Focus:cancer & tumor microenvironment· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:differential expression· 1

Frequent Co-Authors

Ebtihal H MustafaiD· 2 shared Julia V. MilneiD· 2 shared Kameng Wu· 2 shared Katherine Papastratos· 2 shared Kaylene J. SimpsoniD· 2 shared Kylie L. GorringeiD· 2 shared Nicholas James ClemonsiD· 2 shared Niko ThioiD· 2 shared

Activity by Year

2024-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Ebtihal H MustafaORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Mapping Functional Tumor Suppressor Networks in Esophageal Adenocarcinoma Using In Vivo CRISPR Screening and Perturb-sequencing

Ebtihal H Mustafa, Katherine Papastratos, Kameng Wu, Niko Thio, Julia V. Milne, Natasha Mitchell, Sasha Witts, Maree Pechlivanis, Bonnie Wong, Nicola Waddell, Wayne Allen Phillips, Nicholas James Clemons

The paper identifies tumor suppressors and their functional roles in esophageal adenocarcinoma progression using CRISPR screening and Perturb-seq.

bioRxiv · Jul 21, 2026 · PreprintCancer Biology

Comprehensive drug efficacy data for mucinous ovarian carcinoma using a novel and extensive biobank of patient-derived organoid models

Olivia Craig, Carolina Salazar, Suad M. Abdirahman, Nikita Dalvi, Niveditha Rajadevan, Jennii Luu, Robert Vary, Susanne Ramm, Karla J. Cowley, Ratana Lim, Briony Milesi, Christopher Tagkalidis, Patricia Wojtowicz, Stuart Bencraig, Genevieve Dall, , Kylie L. Gorringe

This paper develops a large biobank of patient-derived MOC organoids and screens them for drug efficacy, finding resistance to standard therapies and effectiveness of less commonly used drugs.

bioRxiv · Apr 9, 2026 · PreprintCancer Biology

SMAD4 loss drives chromosomal instability during tumourigenesis via translational reprogramming

Julia V. Milne, Kameng Wu, Eric P. Kusnadi, Sandra Brosda, Kenji Mark Fujihara, Ebtihal H Mustafa, Sasha Witts, Katherine Papastratos, Maree Pechlivanis, Anna Trigos, Metta K. Jana, Paul J. McMillan, Thomas Daniel Jackson, Niko Thio, Yuzhou Feng, , Nicholas James Clemons

This study shows SMAD4 loss reprograms translation to induce chromosomal instability, driving tumourigenesis, and identifies CDK11B-p58 as a key mediator.

bioRxiv · Mar 25, 2026 · PreprintCancer Biology

Phylogenetic analysis of paired breast carcinomas identifies genetic events associated with clonal recurrence and invasive progression

Tanjina Kader, Maia Zethoven, Sakshi Mahale, Hugo Saunders, Lauren Tjoeka, Rebecca Lehmann, Madawa W Jayawardana, Jia‐Min Pang, Dorothea Lesche, Neeha Rajan, Timothy Semple, Jue Er Amanda Lee, Richard Lupat, David J Byrne, Siobhan Hughes, , Kylie L Gorringe

The paper analyzes paired breast carcinomas to determine if recurrences are clonal or new tumors, finding 7% are non-clonal by whole exome sequencing.

bioRxiv · May 19, 2024Cancer Biology